Veriantara Satya Dhika, . (2021) PROFIL KEAMANAN METFORMIN PADA PASIEN DIABETES MELITUS TIPE DUA DENGAN INFEKSI COVID – 19: TINJAUAN SISTEMATIS. Skripsi thesis, Universitas Pembangunan Nasional Veteran Jakarta.
![[img]](http://repository.upnvj.ac.id/style/images/fileicons/text.png) |
Text
ABSTRAK.pdf Download (166kB) |
|
Text
AWAL.pdf Download (1MB) |
|
Text
BAB 1.pdf Download (108kB) |
|
Text
BAB 2.pdf Restricted to Repository UPNVJ Only Download (1MB) |
|
Text
BAB 3.pdf Restricted to Repository UPNVJ Only Download (152kB) |
|
Text
BAB 4.pdf Restricted to Repository UPNVJ Only Download (573kB) |
|
Text
BAB 5.pdf Download (92kB) |
|
Text
DAFTAR PUSTAKA.pdf Download (267kB) |
|
Text
RIWAYAT HIDUP.pdf Restricted to Repository UPNVJ Only Download (103kB) |
|
Text
LAMPIRAN.pdf Restricted to Repository UPNVJ Only Download (2MB) |
|
Text
ARTIKEL KI.pdf Restricted to Repository staff only Download (462kB) |
Abstract
Diabetes Mellitus (DM) type two is a challenge for the management of COVID-19. Metformin is the treatment of choice for DM type two patients with COVID-19. At this time, there are no studies related to how the safety aspects of these drugs are used in DM type two patients with COVID-19. This study aims to determine the safety profile of metformin in DM type two patients with COVID-19. The method used is systematic with a combination of data from several different database articles, namely PubMed, Medline (Ovid), ScienceDirect, Cochrane Library, ClinicalTrials. gov, and medrxiv.org. A total of 23 study articles from 2020-2021 meet the inclusion criteria and are of very good quality. The results of this study indicate a sufficient safety profile in terms of mortality, good life, hospital and ICU admissions, several comorbidities, risk of complications, diagnosis and severity. Based on its safety profile, metformin remains a definite use for type 2 DM patients with COVID-19 infection.
| Item Type: | Thesis (Skripsi) |
|---|---|
| Additional Information: | [No. Panggil: 1710211106] [Pembimbing: Ryan Herardi] [Penguji 1: Andri Pramesyanti Pramono] [Penguji 2: Ryan Herardi] |
| Uncontrolled Keywords: | DM Type two, Metformin, Safety Profile |
| Subjects: | R Medicine > RC Internal medicine |
| Divisions: | Fakultas Kedokteran > Program Studi Kedokteran (S1) |
| Depositing User: | Veriantara Satya Dhika |
| Date Deposited: | 18 May 2022 06:55 |
| Last Modified: | 18 May 2022 06:55 |
| URI: | http://repository.upnvj.ac.id/id/eprint/11602 |
Actions (login required)
 |
View Item |